| Prev Close | 315.03 |
| Day Low/High | 311.30 / 319.34 |
| 52 Wk Low/High | 244.28 / 330.00 |
| Avg Volume | 1.23M |
| Exchange | NASDAQ |
| Shares Outstanding | 211.43M |
| Market Cap | 66.61B |
| EPS | 17.00 |
| P/E Ratio | 20.67 |
| Div & Yield | N.A. (N.A) |
Today's breakout move in the stock is a highlight of the surging sector.
Today's breakout move in the stock is a highlight of the surging sector.
Biogen (NASDAQ: BIIB) today announced results from a recently conducted analysis of the long-term extension (LTE) of its ongoing Phase 1b study of aducanumab, the company's investigational treatment for early...
The European Commission (EC) granted a marketing authorization for IMRALDI ® (also known as SB5), an adalimumab biosimilar referencing Humira ®.
'Biogen has a relatively under-leverage balance sheet, and we expect [free cash flow yield] and US cash to grow.'
Pfizer post earnings beat.
Biogen (NASDAQ:BIIB)Â today announced the appointment of Anabella Villalobos, Ph.
The agreement is the first to apply value-based contracts to cover Medicaid patients in the United States.
The agreement is the first to apply value-based contracts to cover patients in Puerto Rico.
The Justice Department is investigating the company's charitable contributions for kickbacks and false claims.
The S&P 500 and Nasdaq end at records.
Novavax, Medicines Co. and Biogen were among the biotech stock movers in premarket trading on July 25.
These disparate names seem to fit quite well with the investment approach of the Oracle of Omaha.
U.S. stock futures turn higher on Tuesday following earnings from Alphabet.
Biogen Inc. (NASDAQ: BIIB) today reported second quarter 2017 financial results, including: Total revenues of $3.
Biogen (NASDAQ: BIIB) announced today the appointment of Alisha A.
Wall Street's first glimpse at the second quarter.
Here are the activist investor's next potential targets.
Biogen (NASDAQ: BIIB) will present data from its Alzheimer's disease programs at the Alzheimer's Association International Conference® 2017 (AAIC®) in London, July 16 - 20, 2017.
